These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
190 related articles for article (PubMed ID: 35205790)
1. Plasma Gelsolin Confers Chemoresistance in Ovarian Cancer by Resetting the Relative Abundance and Function of Macrophage Subtypes. Asare-Werehene M; Tsuyoshi H; Zhang H; Salehi R; Chang CY; Carmona E; Librach CL; Mes-Masson AM; Chang CC; Burger D; Yoshida Y; Tsang BK Cancers (Basel); 2022 Feb; 14(4):. PubMed ID: 35205790 [TBL] [Abstract][Full Text] [Related]
2. The regulation of plasma gelsolin by DNA methylation in ovarian cancer chemo-resistance. Manzoor HB; Asare-Werehene M; Pereira SD; Satyamoorthy K; Tsang BK J Ovarian Res; 2024 Jan; 17(1):15. PubMed ID: 38216951 [TBL] [Abstract][Full Text] [Related]
3. Plasma Gelsolin Inhibits Natural Killer Cell Function and Confers Chemoresistance in Epithelial Ovarian Cancer. Onuma T; Asare-Werehene M; Fujita Y; Yoshida Y; Tsang BK Cells; 2024 May; 13(11):. PubMed ID: 38891037 [TBL] [Abstract][Full Text] [Related]
4. Exosomal Plasma Gelsolin Is an Immunosuppressive Mediator in the Ovarian Tumor Microenvironment and a Determinant of Chemoresistance. Onuma T; Asare-Werehene M; Yoshida Y; Tsang BK Cells; 2022 Oct; 11(20):. PubMed ID: 36291171 [TBL] [Abstract][Full Text] [Related]
5. The exosome-mediated autocrine and paracrine actions of plasma gelsolin in ovarian cancer chemoresistance. Asare-Werehene M; Nakka K; Reunov A; Chiu CT; Lee WT; Abedini MR; Wang PW; Shieh DB; Dilworth FJ; Carmona E; Le T; Mes-Masson AM; Burger D; Tsang BK Oncogene; 2020 Feb; 39(7):1600-1616. PubMed ID: 31700155 [TBL] [Abstract][Full Text] [Related]
6. Predicting chemoresponsiveness in epithelial ovarian cancer patients using circulating small extracellular vesicle-derived plasma gelsolin. Gerber E; Asare-Werehene M; Reunov A; Burger D; Le T; Carmona E; Mes-Masson AM; Tsang BK J Ovarian Res; 2023 Jan; 16(1):14. PubMed ID: 36642715 [TBL] [Abstract][Full Text] [Related]
7. The Application of an Extracellular Vesicle-Based Biosensor in Early Diagnosis and Prediction of Chemoresponsiveness in Ovarian Cancer. Asare-Werehene M; Hunter RA; Gerber E; Reunov A; Brine I; Chang CY; Chang CC; Shieh DB; Burger D; Anis H; Tsang BK Cancers (Basel); 2023 Apr; 15(9):. PubMed ID: 37174032 [TBL] [Abstract][Full Text] [Related]
8. Plasma Gelsolin Inhibits CD8 Asare-Werehene M; Communal L; Carmona E; Han Y; Song YS; Burger D; Mes-Masson AM; Tsang BK Cancer Res; 2020 Sep; 80(18):3959-3971. PubMed ID: 32641415 [TBL] [Abstract][Full Text] [Related]
9. Pre-operative Circulating Plasma Gelsolin Predicts Residual Disease and Detects Early Stage Ovarian Cancer. Asare-Werehene M; Communal L; Carmona E; Le T; Provencher D; Mes-Masson AM; Tsang BK Sci Rep; 2019 Sep; 9(1):13924. PubMed ID: 31558772 [TBL] [Abstract][Full Text] [Related]
10. Plasma gelsolin improves lung host defense against pneumonia by enhancing macrophage NOS3 function. Yang Z; Chiou TT; Stossel TP; Kobzik L Am J Physiol Lung Cell Mol Physiol; 2015 Jul; 309(1):L11-6. PubMed ID: 25957291 [TBL] [Abstract][Full Text] [Related]
11. Macrophage Checkpoint Nanoimmunotherapy Has the Potential to Reduce Malignant Progression in Bioengineered VandenHeuvel SN; Chau E; Mohapatra A; Dabbiru S; Roy S; O'Connell C; Kamat A; Godin B; Raghavan SA ACS Appl Bio Mater; 2024 Dec; 7(12):7871-7882. PubMed ID: 38558434 [TBL] [Abstract][Full Text] [Related]
12. Identification of three molecular subtypes based on immune infiltration in ovarian cancer and its prognostic value. Liu J; Tan Z; He J; Jin T; Han Y; Hu L; Song J; Huang S Biosci Rep; 2020 Oct; 40(10):. PubMed ID: 33043974 [TBL] [Abstract][Full Text] [Related]
14. p53 Promotes chemoresponsiveness by regulating hexokinase II gene transcription and metabolic reprogramming in epithelial ovarian cancer. Han CY; Patten DA; Lee SG; Parks RJ; Chan DW; Harper ME; Tsang BK Mol Carcinog; 2019 Nov; 58(11):2161-2174. PubMed ID: 31486135 [TBL] [Abstract][Full Text] [Related]
15. Adenosine-generating ovarian cancer cells attract myeloid cells which differentiate into adenosine-generating tumor associated macrophages - a self-amplifying, CD39- and CD73-dependent mechanism for tumor immune escape. Montalbán Del Barrio I; Penski C; Schlahsa L; Stein RG; Diessner J; Wöckel A; Dietl J; Lutz MB; Mittelbronn M; Wischhusen J; Häusler SFM J Immunother Cancer; 2016; 4():49. PubMed ID: 27532024 [TBL] [Abstract][Full Text] [Related]
16. Plasma Gelsolin Enhances Phagocytosis of Candida auris by Human Neutrophils through Scavenger Receptor Class B. Suprewicz Ł; Skłodowski K; Walewska A; Deptuła P; Sadzyńska A; Eljaszewicz A; Moniuszko M; Janmey PA; Bucki R Microbiol Spectr; 2023 Feb; 11(2):e0408222. PubMed ID: 36802172 [TBL] [Abstract][Full Text] [Related]
17. Adipocytes promote ovarian cancer chemoresistance. Yang J; Zaman MM; Vlasakov I; Roy R; Huang L; Martin CR; Freedman SD; Serhan CN; Moses MA Sci Rep; 2019 Sep; 9(1):13316. PubMed ID: 31527632 [TBL] [Abstract][Full Text] [Related]
18. Plasma gelsolin: a general prognostic marker of health. Peddada N; Sagar A; Ashish ; Garg R Med Hypotheses; 2012 Feb; 78(2):203-10. PubMed ID: 22082609 [TBL] [Abstract][Full Text] [Related]
19. [Plasma gelsolin level and its relationship with the prognosis of patients with severe burns]. Huang LF; Yao YM; Dong N; He LX; Zhang QH; Yu Y; Sheng ZY Zhonghua Shao Shang Za Zhi; 2013 Apr; 29(2):148-51. PubMed ID: 23985203 [TBL] [Abstract][Full Text] [Related]
20. Plasma gelsolin protects HIV-1 gp120-induced neuronal injury via voltage-gated K+ channel Kv2.1. Liu H; Liu J; Liang S; Xiong H Mol Cell Neurosci; 2013 Nov; 57():73-82. PubMed ID: 24416794 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]